Prestige Biologics Co., Ltd.

KOSDAQ:A334970 Stock Report

Market Cap: ₩440.5b

Prestige Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A334970?
Owner TypeNumber of SharesOwnership Percentage
Institutions13,7370.0177%
Private Companies3,248,5844.2%
Individual Insiders15,708,62520.3%
General Public27,323,96335.3%
Public Companies31,122,72840.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.4%.


Top Shareholders

Top 11 shareholders own 64.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
40.2%
Prestige BioPharma Limited
31,122,728₩177.1b105%no data
10.1%
So-Yeon Park
7,807,821₩44.4b0%no data
9.96%
Jinwoo Kim
7,711,601₩43.9b0%no data
4.2%
Octava Fund Limited
3,248,584₩18.5b0%no data
0.1%
Hyuncheol Dong
80,000₩455.2m0%no data
0.058%
Jae-Yeong Yang
45,000₩256.1m0%no data
0.036%
Deok-hun Hyeon
27,962₩159.1m0%no data
0.024%
Youngsu Lim
18,449₩105.0m0%no data
0.02%
Lai Way Tay
15,792₩89.9m0%no data
0.018%
State Street Global Advisors, Inc.
13,737₩78.1m-0.99%no data
0.0026%
Seok-jae Seo
2,000₩11.4m0%no data